First-of-its-kind study concludes that 1996 release of OxyContin played major role in the opioid crisis

First-of-its-kind study concludes that 1996 release of OxyContin played major role in the opioid crisis

Publication date: Dec 03, 2019

Purdue Pharma’s 1996 release of OxyContin led to increased opioid overdose deaths in the past two decades and was a primary cause of the opioid epidemic plaguing the country, according to a new study.

The authors estimated that if states without the triplicate program had the same level of exposure to OxyContin as states that had the triplicate prescribing program in place, they would have had 36% fewer drug overdose deaths and 44% fewer opioid overdose deaths on average in each year from 1996-2017.

-Overall, we find strong evidence that the marketing practices of OxyContin interacted with state-level policy conditions led to dramatically reduced overdose death rates in triplicate states,” the authors wrote.

Concepts Keywords
Bankruptcy Drug overdose
Drug Overdose Oxycodone
Epidemic Purdue Pharma
Hydrocodone Morphinans
Methadone Euphoriants
Narcotics Sackler family
Notre Dame Psychoactive drugs
Opioid RTT
Opioid Addiction Opioids
Opioid Epidemic Pharmaceutical manufacturer
Opioid Overdose Empirical basis theories
Opioids Advertising plans
Overdose
Overdose Deaths
Oxycodone
OxyContin
Pennsylvania
Pharmaceutical
Pharmacist
Purdue
Purdue Pharma
RAND Corporation

Semantics

Type Source Name
pathway REACTOME Release
disease MESH growth
disease MESH death
drug DRUGBANK Oxycodone
drug DRUGBANK Hydrocodone
drug DRUGBANK Methadone
disease MESH opioid addiction

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *